More articles from Commentary
- GUSTO V: Should it affect clinical practice?
The results of GUSTO V were equivocal and should not lead physicians to change how they treat myocardial infarction.
- The dangers of self-monitored dieting: What are our patients really doing?
Patient-monitored diets often leave questions of adherence and safety unanswered.
- C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
CRP elevations are a sensitive test for inflammation, hut are not specific.
- In cholesterol lowering, moderation kills
The author’s experience indicates that a low-fat, plant-based diet can lower cholesterol to less than 150 mg/dL and reverse coronary artery disease.
- Of rice, grain, and zeal: Lessons from Drs. Kempner and Esselstyn
Two physicians who successfully motivated their patients to make lifestyle changes were true believers.
- Fibrinolytic therapy in the elderly: Making sense of troubling new findings
Do patients older than 75 years with acute MI benefit from fibrinolytic therapy? For now, we have to live with uncertainty.
- Where to draw the line using statins: Lessons from 4S to AFCAPS/TexCAPS
For patients at low risk, a treatment that is beneficial statistically may not be practical or economical. But how should this question be decided? And who should decide?
- Do today's medical residents really have it better?
Despite changes designed to make medical education more humane, it is not easier to be an intern or resident today.
- The dark side of evidence-based medicine
Clinical judgement – utilizing personal experience, analogy and extrapolation – is still necessary in a system of evidence-based medicine.